Pharmafile Logo

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this most interesting of seasons.

- PMLiVE

In our new whitepaper, we share the current challenges and priorities that digital pharma leaders are finding in 2024.

Connectivity underpins innovation and efficiency, enabling improved outcomes for patients and HCPs.

Our latest research reveals the need for increased connection across the pharma sector — linking data with actionable insights, joining up internal teams, improving interactions between end users and providers, connecting digital systems and platforms, and aligning long-term goals with short-term priorities.

Drawing on the survey data, along with opinions from expert contributors and Graphite’s own sector experience, we explore how pharma teams can overcome challenges to achieve success with their digital solutions and strategies.

Based on first-hand insight from pharma leaders working within Commercial, Medical, Marketing and Digital roles across the USA and Europe.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

5 key digital CX challenges in pharma, and how to start solving them

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

Driving behaviour change for positive patient outcomes in pharma

Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...

How to successfully manage change and enable digital transformation within pharma

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Ensuring a seamless transition from design to development: Strategies for successful collaboration

When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.